EP3233837 - TETRAHYDROQUINOLINE SULFONAMIDE DERIVATIVES AS INVERSE AGONISTS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA (T)) [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 11.10.2019 Database last updated on 02.09.2024 | |
Former | The patent has been granted Status updated on 02.11.2018 | ||
Former | Grant of patent is intended Status updated on 05.07.2018 | ||
Former | Request for examination was made Status updated on 22.09.2017 | ||
Former | The international publication has been made Status updated on 31.03.2017 | Most recent event Tooltip | 03.07.2020 | Lapse of the patent in a contracting state New state(s): CY, HU, MK | published on 05.08.2020 [2020/32] | Applicant(s) | For all designated states Galderma Research & Development 2400 Route des Colles Les Templiers 06410 Biot / FR | [2017/43] | Inventor(s) | 01 /
MUSICKI, Branislav 15 Rue Verdi Bâtiment B 06000 Nice / FR | 02 /
OUVRY, Gilles 35 Avenue Saint Philippe 06410 Biot / FR | 03 /
THOREAU, Etienne 8 allée Saint-Pons 06460 Saint Vallier de Thiey / FR | 04 /
BOUIX-PETER, Claire 48 chemin du Cannet 06220 Vallauris / FR | [2017/43] | Representative(s) | Casalonga Casalonga & Partners Bayerstraße 71/73 80335 München / DE | [2017/43] | Application number, filing date | 15817295.7 | 18.12.2015 | [2017/43] | WO2015EP80690 | Priority number, date | FR20140063035 | 19.12.2014 Original published format: FR 1463035 | FR20150056341 | 03.07.2015 Original published format: FR 1556341 | [2017/43] | Filing language | FR | Procedural language | FR | Publication | Type: | A1 Application with search report | No.: | WO2016097392 | Date: | 23.06.2016 | Language: | FR | [2016/25] | Type: | A1 Application with search report | No.: | EP3233837 | Date: | 25.10.2017 | Language: | FR | The application published by WIPO in one of the EPO official languages on 23.06.2016 takes the place of the publication of the European patent application. | [2017/43] | Type: | B1 Patent specification | No.: | EP3233837 | Date: | 05.12.2018 | Language: | FR | [2018/49] | Search report(s) | International search report - published on: | EP | 23.06.2016 | Classification | IPC: | C07D405/06, C07D401/06, C07D409/06, C07D215/36, C07D401/04, C07D413/06, C07D409/04, C07D405/12, C07D405/04, A61K31/4709, A61P17/00 | [2017/43] | CPC: |
C07D413/06 (EP,CN,KR,RU,US);
C07D405/06 (EP,CN,KR,RU,US);
C07D233/70 (CN);
A61K31/4184 (KR,RU);
A61K31/4439 (KR,RU);
A61P17/04 (EP,RU,US);
A61P17/06 (EP,RU,US);
A61P17/10 (EP,RU,US);
C07D209/34 (EP,CN,US);
C07D215/36 (EP,CN,US);
C07D231/54 (CN);
C07D231/56 (EP,CN,US);
C07D235/26 (US);
C07D241/08 (CN);
C07D249/18 (CN);
C07D261/08 (CN);
C07D307/79 (EP,CN,US);
C07D309/04 (CN);
C07D401/04 (EP,CN,RU,US);
C07D401/06 (EP,CN,KR,RU,US);
C07D401/14 (EP,US);
C07D403/04 (EP,CN,US);
C07D403/06 (EP,CN,RU,US);
C07D405/04 (EP,CN,RU,US);
C07D405/12 (EP,CN,US);
C07D405/14 (EP,CN,RU,US);
C07D407/04 (EP,CN,US);
C07D409/04 (EP,CN,US);
C07D409/06 (EP,CN,RU,US);
C07D417/06 (EP,CN,US);
C07D471/10 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/43] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | TETRAHYDROCHINOLINSULFONAMIDDERIVATE ALS INVERSE AGONISTEN VON RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA (T)) | [2017/43] | English: | TETRAHYDROQUINOLINE SULFONAMIDE DERIVATIVES AS INVERSE AGONISTS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA (T)) | [2017/43] | French: | DÉRIVÉS TÉTRAHYDROQUINOLINES SULFONAMIDES EN TANT QU'AGONISTES INVERSES DU RÉCEPTEUR GAMMA ORPHELIN ASSOCIÉ AUX RÉTINOÏDES ROR GAMMA (T) | [2017/43] | Entry into regional phase | 12.07.2017 | National basic fee paid | 12.07.2017 | Designation fee(s) paid | 12.07.2017 | Examination fee paid | Examination procedure | 12.07.2017 | Examination requested [2017/43] | 12.07.2017 | Date on which the examining division has become responsible | 06.07.2018 | Communication of intention to grant the patent | 17.10.2018 | Fee for grant paid | 17.10.2018 | Fee for publishing/printing paid | 17.10.2018 | Receipt of the translation of the claim(s) | Opposition(s) | 06.09.2019 | No opposition filed within time limit [2019/46] | Fees paid | Renewal fee | 12.12.2017 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 18.12.2015 | AL | 05.12.2018 | AT | 05.12.2018 | CY | 05.12.2018 | CZ | 05.12.2018 | DK | 05.12.2018 | EE | 05.12.2018 | ES | 05.12.2018 | FI | 05.12.2018 | HR | 05.12.2018 | IT | 05.12.2018 | LT | 05.12.2018 | LV | 05.12.2018 | MC | 05.12.2018 | MK | 05.12.2018 | MT | 05.12.2018 | NL | 05.12.2018 | PL | 05.12.2018 | RO | 05.12.2018 | RS | 05.12.2018 | SE | 05.12.2018 | SI | 05.12.2018 | SK | 05.12.2018 | SM | 05.12.2018 | TR | 05.12.2018 | IE | 18.12.2018 | LU | 18.12.2018 | BE | 31.12.2018 | CH | 31.12.2018 | LI | 31.12.2018 | BG | 05.03.2019 | NO | 05.03.2019 | GR | 06.03.2019 | IS | 05.04.2019 | PT | 05.04.2019 | [2020/31] |
Former [2020/17] | AL | 05.12.2018 | |
AT | 05.12.2018 | ||
CZ | 05.12.2018 | ||
DK | 05.12.2018 | ||
EE | 05.12.2018 | ||
ES | 05.12.2018 | ||
FI | 05.12.2018 | ||
HR | 05.12.2018 | ||
IT | 05.12.2018 | ||
LT | 05.12.2018 | ||
LV | 05.12.2018 | ||
MC | 05.12.2018 | ||
MT | 05.12.2018 | ||
NL | 05.12.2018 | ||
PL | 05.12.2018 | ||
RO | 05.12.2018 | ||
RS | 05.12.2018 | ||
SE | 05.12.2018 | ||
SI | 05.12.2018 | ||
SK | 05.12.2018 | ||
SM | 05.12.2018 | ||
TR | 05.12.2018 | ||
IE | 18.12.2018 | ||
LU | 18.12.2018 | ||
BE | 31.12.2018 | ||
CH | 31.12.2018 | ||
LI | 31.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
GR | 06.03.2019 | ||
IS | 05.04.2019 | ||
PT | 05.04.2019 | ||
Former [2020/08] | AL | 05.12.2018 | |
AT | 05.12.2018 | ||
CZ | 05.12.2018 | ||
DK | 05.12.2018 | ||
EE | 05.12.2018 | ||
ES | 05.12.2018 | ||
FI | 05.12.2018 | ||
HR | 05.12.2018 | ||
IT | 05.12.2018 | ||
LT | 05.12.2018 | ||
LV | 05.12.2018 | ||
MC | 05.12.2018 | ||
MT | 05.12.2018 | ||
NL | 05.12.2018 | ||
PL | 05.12.2018 | ||
RO | 05.12.2018 | ||
RS | 05.12.2018 | ||
SE | 05.12.2018 | ||
SI | 05.12.2018 | ||
SK | 05.12.2018 | ||
SM | 05.12.2018 | ||
IE | 18.12.2018 | ||
LU | 18.12.2018 | ||
BE | 31.12.2018 | ||
CH | 31.12.2018 | ||
LI | 31.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
GR | 06.03.2019 | ||
IS | 05.04.2019 | ||
PT | 05.04.2019 | ||
Former [2020/04] | AL | 05.12.2018 | |
AT | 05.12.2018 | ||
CZ | 05.12.2018 | ||
DK | 05.12.2018 | ||
EE | 05.12.2018 | ||
ES | 05.12.2018 | ||
FI | 05.12.2018 | ||
HR | 05.12.2018 | ||
IT | 05.12.2018 | ||
LT | 05.12.2018 | ||
LV | 05.12.2018 | ||
MC | 05.12.2018 | ||
NL | 05.12.2018 | ||
PL | 05.12.2018 | ||
RO | 05.12.2018 | ||
RS | 05.12.2018 | ||
SE | 05.12.2018 | ||
SI | 05.12.2018 | ||
SK | 05.12.2018 | ||
SM | 05.12.2018 | ||
IE | 18.12.2018 | ||
LU | 18.12.2018 | ||
BE | 31.12.2018 | ||
CH | 31.12.2018 | ||
LI | 31.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
GR | 06.03.2019 | ||
IS | 05.04.2019 | ||
PT | 05.04.2019 | ||
Former [2019/50] | AL | 05.12.2018 | |
AT | 05.12.2018 | ||
CZ | 05.12.2018 | ||
DK | 05.12.2018 | ||
EE | 05.12.2018 | ||
ES | 05.12.2018 | ||
FI | 05.12.2018 | ||
HR | 05.12.2018 | ||
IT | 05.12.2018 | ||
LT | 05.12.2018 | ||
LV | 05.12.2018 | ||
MC | 05.12.2018 | ||
NL | 05.12.2018 | ||
PL | 05.12.2018 | ||
RO | 05.12.2018 | ||
RS | 05.12.2018 | ||
SE | 05.12.2018 | ||
SI | 05.12.2018 | ||
SK | 05.12.2018 | ||
SM | 05.12.2018 | ||
IE | 18.12.2018 | ||
LU | 18.12.2018 | ||
BE | 31.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
GR | 06.03.2019 | ||
IS | 05.04.2019 | ||
PT | 05.04.2019 | ||
Former [2019/48] | AL | 05.12.2018 | |
AT | 05.12.2018 | ||
CZ | 05.12.2018 | ||
DK | 05.12.2018 | ||
EE | 05.12.2018 | ||
ES | 05.12.2018 | ||
FI | 05.12.2018 | ||
HR | 05.12.2018 | ||
IT | 05.12.2018 | ||
LT | 05.12.2018 | ||
LV | 05.12.2018 | ||
MC | 05.12.2018 | ||
NL | 05.12.2018 | ||
PL | 05.12.2018 | ||
RO | 05.12.2018 | ||
RS | 05.12.2018 | ||
SE | 05.12.2018 | ||
SK | 05.12.2018 | ||
SM | 05.12.2018 | ||
IE | 18.12.2018 | ||
LU | 18.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
GR | 06.03.2019 | ||
IS | 05.04.2019 | ||
PT | 05.04.2019 | ||
Former [2019/45] | AL | 05.12.2018 | |
AT | 05.12.2018 | ||
CZ | 05.12.2018 | ||
EE | 05.12.2018 | ||
ES | 05.12.2018 | ||
FI | 05.12.2018 | ||
HR | 05.12.2018 | ||
IT | 05.12.2018 | ||
LT | 05.12.2018 | ||
LV | 05.12.2018 | ||
MC | 05.12.2018 | ||
NL | 05.12.2018 | ||
PL | 05.12.2018 | ||
RO | 05.12.2018 | ||
RS | 05.12.2018 | ||
SE | 05.12.2018 | ||
SK | 05.12.2018 | ||
SM | 05.12.2018 | ||
LU | 18.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
GR | 06.03.2019 | ||
IS | 05.04.2019 | ||
PT | 05.04.2019 | ||
Former [2019/39] | AL | 05.12.2018 | |
AT | 05.12.2018 | ||
CZ | 05.12.2018 | ||
EE | 05.12.2018 | ||
ES | 05.12.2018 | ||
FI | 05.12.2018 | ||
HR | 05.12.2018 | ||
IT | 05.12.2018 | ||
LT | 05.12.2018 | ||
LV | 05.12.2018 | ||
NL | 05.12.2018 | ||
PL | 05.12.2018 | ||
RO | 05.12.2018 | ||
RS | 05.12.2018 | ||
SE | 05.12.2018 | ||
SK | 05.12.2018 | ||
SM | 05.12.2018 | ||
LU | 18.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
GR | 06.03.2019 | ||
IS | 05.04.2019 | ||
PT | 05.04.2019 | ||
Former [2019/37] | AL | 05.12.2018 | |
AT | 05.12.2018 | ||
CZ | 05.12.2018 | ||
EE | 05.12.2018 | ||
ES | 05.12.2018 | ||
FI | 05.12.2018 | ||
HR | 05.12.2018 | ||
IT | 05.12.2018 | ||
LT | 05.12.2018 | ||
LV | 05.12.2018 | ||
NL | 05.12.2018 | ||
PL | 05.12.2018 | ||
RO | 05.12.2018 | ||
RS | 05.12.2018 | ||
SE | 05.12.2018 | ||
SM | 05.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
GR | 06.03.2019 | ||
PT | 05.04.2019 | ||
Former [2019/35] | AL | 05.12.2018 | |
AT | 05.12.2018 | ||
CZ | 05.12.2018 | ||
ES | 05.12.2018 | ||
FI | 05.12.2018 | ||
HR | 05.12.2018 | ||
IT | 05.12.2018 | ||
LT | 05.12.2018 | ||
LV | 05.12.2018 | ||
NL | 05.12.2018 | ||
PL | 05.12.2018 | ||
RS | 05.12.2018 | ||
SE | 05.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
GR | 06.03.2019 | ||
PT | 05.04.2019 | ||
Former [2019/34] | AL | 05.12.2018 | |
AT | 05.12.2018 | ||
ES | 05.12.2018 | ||
FI | 05.12.2018 | ||
HR | 05.12.2018 | ||
IT | 05.12.2018 | ||
LT | 05.12.2018 | ||
LV | 05.12.2018 | ||
NL | 05.12.2018 | ||
RS | 05.12.2018 | ||
SE | 05.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
GR | 06.03.2019 | ||
PT | 05.04.2019 | ||
Former [2019/33] | AL | 05.12.2018 | |
AT | 05.12.2018 | ||
ES | 05.12.2018 | ||
FI | 05.12.2018 | ||
HR | 05.12.2018 | ||
LT | 05.12.2018 | ||
LV | 05.12.2018 | ||
NL | 05.12.2018 | ||
RS | 05.12.2018 | ||
SE | 05.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
GR | 06.03.2019 | ||
PT | 05.04.2019 | ||
Former [2019/30] | AL | 05.12.2018 | |
AT | 05.12.2018 | ||
ES | 05.12.2018 | ||
FI | 05.12.2018 | ||
HR | 05.12.2018 | ||
LT | 05.12.2018 | ||
LV | 05.12.2018 | ||
NL | 05.12.2018 | ||
RS | 05.12.2018 | ||
SE | 05.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
GR | 06.03.2019 | ||
Former [2019/26] | AL | 05.12.2018 | |
AT | 05.12.2018 | ||
ES | 05.12.2018 | ||
FI | 05.12.2018 | ||
HR | 05.12.2018 | ||
LT | 05.12.2018 | ||
LV | 05.12.2018 | ||
RS | 05.12.2018 | ||
SE | 05.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
GR | 06.03.2019 | ||
Former [2019/25] | AT | 05.12.2018 | |
ES | 05.12.2018 | ||
FI | 05.12.2018 | ||
HR | 05.12.2018 | ||
LT | 05.12.2018 | ||
LV | 05.12.2018 | ||
RS | 05.12.2018 | ||
SE | 05.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
GR | 06.03.2019 | ||
Former [2019/24] | AT | 05.12.2018 | |
ES | 05.12.2018 | ||
FI | 05.12.2018 | ||
HR | 05.12.2018 | ||
LT | 05.12.2018 | ||
LV | 05.12.2018 | ||
SE | 05.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
GR | 06.03.2019 | ||
Former [2019/23] | AT | 05.12.2018 | |
ES | 05.12.2018 | ||
FI | 05.12.2018 | ||
HR | 05.12.2018 | ||
LT | 05.12.2018 | ||
LV | 05.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
Former [2019/22] | FI | 05.12.2018 | |
LT | 05.12.2018 | ||
BG | 05.03.2019 | ||
NO | 05.03.2019 | ||
Former [2019/21] | FI | 05.12.2018 | |
LT | 05.12.2018 | ||
NO | 05.03.2019 | ||
Former [2019/20] | LT | 05.12.2018 | |
NO | 05.03.2019 | Cited in | International search | [A]WO2011137089 (US HEALTH [US], et al) [A] 1-16* claims 1, 2, 7, 22; compound 41 *; | [AD]WO2013160418 (GLAXO GROUP LTD [GB]) [AD] 1-16 * claims 1, 31-34, 37; compounds E6, 102 *; | [AD]WO2014090712 (HOFFMANN LA ROCHE [CH], et al) [AD] 1-16 * page 1, paragraphs 1-3; examples 2, 6, 11, 16, ...; claims 1, 2, 34, 36 *; | [A] - YAN ZHANG ET AL, "Discovery of 2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide derivatives as new ROR[gamma] inhibitors using virtual screening, synthesis and biological evaluation", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, (20140322), vol. 78, doi:10.1016/J.EJMECH.2014.03.065, ISSN 0223-5234, pages 431 - 441, XP028847891 [A] 1-16 * the whole document * * table 3 * DOI: http://dx.doi.org/10.1016/j.ejmech.2014.03.065 |